Month: August 2021

BROVANA® (arformoterol tartrate)

BROVANA® (arformoterol tartrate)

BROVANA Inhalation Solution is a long-acting beta2-adrenergic agonist ( beta2-agonist) indicated for the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema